Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Otto Cars

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
Upsala Journal of Medical Sciences|April 17, 2014
Access, excess, and ethics--towards a sustainable distribution model for antibioticsGabriel Heyman, Otto Cars, Maria-Teresa Bejarano, et al.
The Journal of Antimicrobial Chemotherapy|March 13, 2013
Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic modelThomas Tängdén, Marlen Adler, Otto Cars, et al.
BMJ (Clinical Research Ed.)|April 12, 2012
3Rs for innovating novel antibiotics: sharing resources, risks, and rewardsAnthony D So, Quentin Ruiz-Esparza, Neha Gupta, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2011
Posaconazole in human serum: a greater pharmacodynamic effect than predicted by the non-protein-bound serum concentrationAnders Lignell, Elisabeth Löwdin, Otto Cars, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Voriconazole-induced inhibition of the fungicidal activity of amphotericin B in Candida strains with reduced susceptibility to voriconazole: an effect not predicted by the MIC value aloneAnders Lignell, Elisabeth Löwdin, Otto Cars, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2007
Clinical and economic impact of common multidrug-resistant gram-negative bacilliChristian G Giske, Dominique L Monnet, Otto Cars, et al.
The Journal of Antimicrobial Chemotherapy|December 15, 2015
Prevalence of hypermutators among clinical Acinetobacter baumannii isolatesPatricia Komp Lindgren, Paul G Higgins, Harald Seifert, et al.
Antimicrobial Agents and Chemotherapy|November 24, 2005
Pharmacodynamic model to describe the concentration-dependent selection of cefotaxime-resistant Escherichia coliSara K Olofsson, Patricia Geli, Dan I Andersson, et al.
Scandinavian Journal of Infectious Diseases|June 19, 2002
Antibiotic prescription rates vary markedly between 13 European countriesSigvard Mölstad, Cecilia Stålsby Lundborg, Anna-Karin Karlsson, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 23, 2009
Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MSBritt Jansson, Matti Karvanen, Otto Cars, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Upsala Journal of Medical Sciences|April 17, 2014
Access, excess, and ethics--towards a sustainable distribution model for antibioticsGabriel Heyman, Otto Cars, Maria-Teresa Bejarano, et al.
The Journal of Antimicrobial Chemotherapy|March 13, 2013
Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic modelThomas Tängdén, Marlen Adler, Otto Cars, et al.
BMJ (Clinical Research Ed.)|April 12, 2012
3Rs for innovating novel antibiotics: sharing resources, risks, and rewardsAnthony D So, Quentin Ruiz-Esparza, Neha Gupta, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2011
Posaconazole in human serum: a greater pharmacodynamic effect than predicted by the non-protein-bound serum concentrationAnders Lignell, Elisabeth Löwdin, Otto Cars, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Voriconazole-induced inhibition of the fungicidal activity of amphotericin B in Candida strains with reduced susceptibility to voriconazole: an effect not predicted by the MIC value aloneAnders Lignell, Elisabeth Löwdin, Otto Cars, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2007
Clinical and economic impact of common multidrug-resistant gram-negative bacilliChristian G Giske, Dominique L Monnet, Otto Cars, et al.
The Journal of Antimicrobial Chemotherapy|December 15, 2015
Prevalence of hypermutators among clinical Acinetobacter baumannii isolatesPatricia Komp Lindgren, Paul G Higgins, Harald Seifert, et al.
Antimicrobial Agents and Chemotherapy|November 24, 2005
Pharmacodynamic model to describe the concentration-dependent selection of cefotaxime-resistant Escherichia coliSara K Olofsson, Patricia Geli, Dan I Andersson, et al.
Scandinavian Journal of Infectious Diseases|June 19, 2002
Antibiotic prescription rates vary markedly between 13 European countriesSigvard Mölstad, Cecilia Stålsby Lundborg, Anna-Karin Karlsson, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 23, 2009
Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MSBritt Jansson, Matti Karvanen, Otto Cars, et al.
Pageof 12